Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice.
about
Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-α and bradykinin in human colonic myofibroblasts.The relevance of kinin B1 receptor upregulation in a mouse model of colitisProtein kinase D mediates synergistic expression of COX-2 induced by TNF-{alpha} and bradykinin in human colonic myofibroblasts.Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Bradykinin regulates human colonic ion transport in vitro.Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies.Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis.Amelioration of murine dextran sulfate sodium-induced colitis by ex vivo extracellular superoxide dismutase gene transfer.The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders
P2860
Q35223677-CEA9928B-0252-4447-BABF-33127D98C1F0Q36790176-DB5CDB6E-AF96-48EA-918E-C46F4F29FA06Q37474532-97C0E611-8AF4-4BF3-BD7B-905A6B0AC290Q37789692-17C7A4D6-5711-41D2-AF6E-BFC50A0DF40FQ38011771-92907C67-3D44-4CE5-A08B-347A617A6E20Q38042696-E0AB3194-EF4A-4154-A3CC-4142E3714468Q39964563-B161D1E6-91AF-4098-97CA-9DDCB89FAA5FQ41585199-FFFFB56D-2AD5-4A97-8772-795A720FD6C3Q42271585-8174CB53-339B-4723-A6D4-54FE7A73E36CQ45859332-41017164-1E68-4D06-8F07-BF4D2CBFA9CDQ49804487-11003091-13DA-43C1-A731-85ED19D533A8Q57072601-D1567CA6-9B26-48A8-88B3-B533E0BD26CA
P2860
Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@ast
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@en
type
label
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@ast
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@en
prefLabel
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@ast
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@en
P2093
P356
P1476
Effect of icatibant, a bradyki ...... al ulcerative colitis in mice.
@en
P2093
P2888
P304
P356
10.1023/A:1026694732602
P577
1999-04-01T00:00:00Z
P6179
1024030654